May 2026 FDA Recall Budesonide by Sun Pharmaceutical Industries Inc
D-0607-2026 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on May 29, 2026 for the product Budesonide. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0607-2026

Reason for Recall
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
Initiated
05-29-2026
Reported
06-17-2026
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Nationwide within the United States
Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49.

Batch or Lot Expiration Information

Lot# : BAG0074A, Exp. Date: 1/31/2027.